Can muvalaplin achieve safe and tolerable plasma concentrations adequate to reduce steady-state Lp(a) levels without modulating plasminogen activity in humans?

FHS
August 30, 2023
12:05 pm

Researchers evaluated the tolerability, safety, pharmacodynamics, and pharmacokinetic properties of muvalaplin.

Study identifies 135 genes associated with human skin color

The skin, hair and eye color of more than eight billion humans is determined by the light-absorbing pigment known as melanin.

August 11, 2023

Full focus on the legalization of cannabis and change in management – Biotech Investments

EQS-News: Cannovum Cannabis AG / Key word(s): Strategic Company Decision/Personnel Cannovum Cannabis AG : Cannovum Cannabis AG: Full focus on the legalization of cannabis and

June 20, 2023

Hepalys to develop Inventiva’s NASH treatment; Everest licenses Kezar’s autoimmune drug

Hepalys Pharma said Thursday it will develop and commercialize Inventiva’s nonalcoholic steatohepatitis (NASH) treatment in Japan and South Korea, paying $10 million upfront and up

September 22, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.